Ypsomed Holding AGLTS:0QLQ -0.06%82 Piotroski F-Score is 7 as of Jul. 03, 2026, which is at its 10-year median of 7.00. GuruFocus rates LTS:0QLQ with a GF Score™ of 82/100 and a GF Value™ of CHF397.17 (Fairly Valued). The stock has 4 warning signs investors should review. Among 806 Medical Devices & Instruments companies, Ypsomed Holding AG ranks better than 92.56% on this metric.
Good Sign:
Piotroski F-Score is 7, indicates a very healthy situation.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Ypsomed Holding AG has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.
The historical rank and industry rank for Ypsomed Holding AG's Piotroski F-Score or its related term are showing as below:
LTS:0QLQ'
s Piotroski F-Score Range Over the Past 10 Years
Min: 4 Med: 7 Max: 9
Current: 7
During the past 13 years, the highest Piotroski F-Score of Ypsomed Holding AG was 9. The lowest was 4. And the median was 7.
Ypsomed Holding AG (LTS:0QLQ) Piotroski F-Score Explanation
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
Ypsomed Holding AG Piotroski F-Score Related Terms
Ypsomed Holding AG Piotroski F-Score Historical Data
* Premium members only.
The historical data trend for Ypsomed Holding AG's Piotroski F-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0QLQ vs ISRG, BDX, MDLN: Piotroski F-Score Comparison
For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ypsomed Holding AG Piotroski F-Score vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where Ypsomed Holding AG's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Ypsomed Holding AG's current Net Income (TTM) was 221.9.
==> Positive ==> Score 1.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Ypsomed Holding AG's return on assets of this year was 0.16681963. Ypsomed Holding AG's return on assets of last year was 0.0800098.
==> This year is higher. ==> Score 1.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
Ypsomed Holding AG's gearing of this year was 0.08350511. Ypsomed Holding AG's gearing of last year was 0.08250801.
==> Last year is lower than this year ==> Score 0.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
Ypsomed Holding AG's current ratio of this year was 1.06860341. Ypsomed Holding AG's current ratio of last year was 0.86045959.
==> This year's current ratio is higher. ==> Score 1.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
Ypsomed Holding AG's number of shares in issue this year was 13.608. Ypsomed Holding AG's number of shares in issue last year was 13.648.
==> There is smaller number of shares in issue this year, or the same. ==> Score 1.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
Ypsomed Holding AG's gross margin of this year was 0.43038816. Ypsomed Holding AG's gross margin of last year was 0.39001103.
==> This year's gross margin is higher. ==> Score 1.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
Ypsomed Holding AG's asset turnover of this year was 0.54946965. Ypsomed Holding AG's asset turnover of last year was 0.68473007.
==> Last year's asset turnover is higher ==> Score 0.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
1
+
1
+
1
+
1
+
0
+
1
+
1
+
1
+
0
=
7
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Ypsomed Holding AG has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.
Ypsomed Holding AG (LTS:0QLQ) has a Piotroski F-Score of 7 as of Jul. 03, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Ypsomed Holding AG and its competitors. This is near median its historical median of 7.00. Over the past decade, Ypsomed Holding AG's Piotroski F-Score has ranged from 4.00 to 9.00. According to the industry distribution chart, Ypsomed Holding AG ranks #60 out of 806 companies in the Medical Devices & Instruments industry, placing it in the top 7.4%.
Is Ypsomed Holding AG's Piotroski F-Score too high?
Ypsomed Holding AG's current Piotroski F-Score of 7 is near median its 10-year median of 7.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 9.00. The Medical Devices & Instruments industry median Piotroski F-Score is 5.00. Ypsomed Holding AG's value of 7 is 40% above this industry median. Based on the distribution chart, Ypsomed Holding AG ranks #60 out of 806 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Ypsomed Holding AG has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ypsomed Holding AG's Piotroski F-Score compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Ypsomed Holding AG ranks #60 out of 806 companies for Piotroski F-Score. This places Ypsomed Holding AG in the top 7% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Ypsomed Holding AG's value of 7 is 40% above this benchmark. Historically, Ypsomed Holding AG's own Piotroski F-Score has ranged from 4.00 to 9.00 over the past decade. While the company's 10-year median is 7.00 vs. the industry median of 5.00, Ypsomed Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Devices & Instruments company?
The median Piotroski F-Score among Medical Devices & Instruments companies is 5.00, based on 806 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ypsomed Holding AG's current Piotroski F-Score of 7 is 40% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Ypsomed Holding AG and its competitors. For the Medical Devices & Instruments industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ypsomed Holding AG's current Piotroski F-Score is 7, which is near median its own 10-year median of 7.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ypsomed Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Ypsomed Holding AG (LTS:0QLQ) is currently considered Fairly Valued. The stock's GF Value™ is CHF397.17, compared to a current price of CHF359.40 — trading 9.5% below its estimated fair value. The current Piotroski F-Score is 7, which is near median its 10-year median of 7.00 and 40% above the Medical Devices & Instruments industry median of 5.00. Ypsomed Holding AG's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Ypsomed Holding AG (LTS:0QLQ), the current Piotroski F-Score is 7 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ypsomed Holding AG (LTS:0QLQ) Overvalued in 2026?
Based on GuruFocus' analysis, Ypsomed Holding AG stock appears to be undervalued.
The current stock price of CHF359.40 is trading 9.5% below its estimated GF Value™ of CHF397.17.
GuruFocus considers Ypsomed Holding AG to be Fairly Valued.
Key valuation signals for LTS:0QLQ:
Piotroski F-Score: 7 (near median its 10-year median of 7.00)
GF Value™: CHF397.17 vs. price of CHF359.40 (9.5% below fair value)
Industry Position: 40% above the Medical Devices & Instruments median (#60 of 806)
No single metric tells the full story. See the LTS:0QLQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
82GF Score
Get the complete analysis for LTS:0QLQ
Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0QLQ has been successfully added to your 
